The reduction in the TAF1 expression and the retention of a part of intron 32 in some TAF1 transcripts are currently considered relevant cellular/molecular XDP phenotypes, but their role in XDP pathogenesis is not defined and warrants further investigation. The gene discussed is TAF1; the disease is X-linked dystonia-parkinsonism.